For the ones whom are underestimating this company short term growth potential in these uncertain times, (COVID-19)
I suggest you think twice.......
It appears a lot have purchased shares yesterday, significant volume for such a small market cap.
Majority will hold , some will trade.
Volume of sales will increase significantly in short term.
(we all know that, don't kid yourself)
I am usually not a buyer when a stock significantly goes up in a day, but like many have shown interest in this little gem. on what the product does!
remember there are several bio tech , listed on ASX with a market cap on average $30,000,000 with no income stream in the immediate future.
this little coy is on $11,000,000 market cap with income stream to commence for starters, BUT a product which will help ALL of us in these uncertain times.
If the products helps people in not getting sick , there will be buyers. Why shouldn't I invest then? IMHO.
GLTA
ALLWAYS DYOR, NO ADVICE GIVEN.
Blackphantom
- Forums
- ASX - By Stock
- Ann: SKN enters collaboration with HCT on natural sanitiser
For the ones whom are underestimating this company short term...
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SKN (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.357M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $1.834K | 458.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2078354 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 1346784 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2078354 | 0.004 |
7 | 5242427 | 0.003 |
2 | 835000 | 0.002 |
12 | 7802106 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 1346784 | 4 |
0.006 | 461008 | 1 |
0.007 | 1457000 | 2 |
0.008 | 200000 | 1 |
0.009 | 30000 | 1 |
Last trade - 15.01pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
SKN (ASX) Chart |